Concept information
Preferred term
Immunotherapy, Adoptive
Type
-
Topical Descriptor
Broader concept
Entry terms
- Adoptive Cellular Immunotherapies
- Adoptive Cellular Immunotherapy
- Adoptive Immunotherapies
- Adoptive Immunotherapy
- Cellular Immunotherapies, Adoptive
- Cellular Immunotherapy, Adoptive
- Immunotherapies, Adoptive
- Immunotherapies, Adoptive Cellular
- Immunotherapy, Adoptive Cellular
Note
- for CAR T-Cell Therapy, coordinate with RECEPTORS, CHIMERIC ANTIGEN
Scope note
- Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
History note
- 1991
In other languages
-
Finnish
-
Swedish
URI
http://www.yso.fi/onto/mesh/D016219
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}